Paul Edward Kelly, Director at RELMADA THERAPEUTICS, INC. (RLMD), sold 10,000 shares at $36.33 ($357K) on 2021-03-09, disclosed to the SEC on 2021-03-11.
Open-market sale of $357k RLMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.42 | 3,388 | $120K | 33.6% |
| 2 | $35.42 | 3,388 | $120K | 33.6% |
| 3 | $36.33 | 1,612 | $59K | 16.4% |
| 4 | $36.33 | 1,612 | $59K | 16.4% |
| Total | $35.71 avg | 10,000 | $357K | 100% |
| Filing → |
| RLMD | BUY | 2024-09-11 | $65K | — | Filing → |
| RLMD | SELL | 2022-04-05 | $300K | — | Filing → |
| RLMD | SELL | 2021-02-26 | $338K | — | Filing → |